1. Home
  2. OCS vs HEPS Comparison

OCS vs HEPS Comparison

Compare OCS & HEPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCS
  • HEPS
  • Stock Information
  • Founded
  • OCS 2003
  • HEPS 2000
  • Country
  • OCS Switzerland
  • HEPS Turkey
  • Employees
  • OCS N/A
  • HEPS N/A
  • Industry
  • OCS Biotechnology: Pharmaceutical Preparations
  • HEPS Catalog/Specialty Distribution
  • Sector
  • OCS Health Care
  • HEPS Consumer Discretionary
  • Exchange
  • OCS Nasdaq
  • HEPS Nasdaq
  • Market Cap
  • OCS 869.8M
  • HEPS 834.6M
  • IPO Year
  • OCS N/A
  • HEPS 2021
  • Fundamental
  • Price
  • OCS $21.71
  • HEPS $2.67
  • Analyst Decision
  • OCS Strong Buy
  • HEPS
  • Analyst Count
  • OCS 4
  • HEPS 0
  • Target Price
  • OCS $41.00
  • HEPS N/A
  • AVG Volume (30 Days)
  • OCS 77.9K
  • HEPS 213.8K
  • Earning Date
  • OCS 11-06-2025
  • HEPS 07-30-2025
  • Dividend Yield
  • OCS N/A
  • HEPS N/A
  • EPS Growth
  • OCS N/A
  • HEPS N/A
  • EPS
  • OCS N/A
  • HEPS N/A
  • Revenue
  • OCS $960,668.00
  • HEPS $1,477,672,859.00
  • Revenue This Year
  • OCS $36.75
  • HEPS $37.44
  • Revenue Next Year
  • OCS $1,261.53
  • HEPS $28.46
  • P/E Ratio
  • OCS N/A
  • HEPS N/A
  • Revenue Growth
  • OCS N/A
  • HEPS 49.45
  • 52 Week Low
  • OCS $14.00
  • HEPS $2.19
  • 52 Week High
  • OCS $23.08
  • HEPS $4.05
  • Technical
  • Relative Strength Index (RSI)
  • OCS 76.98
  • HEPS 45.19
  • Support Level
  • OCS $21.19
  • HEPS $2.60
  • Resistance Level
  • OCS $21.79
  • HEPS $2.69
  • Average True Range (ATR)
  • OCS 0.66
  • HEPS 0.07
  • MACD
  • OCS 0.28
  • HEPS -0.00
  • Stochastic Oscillator
  • OCS 93.88
  • HEPS 60.00

About OCS Oculis Holding AG Ordinary shares

Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.

About HEPS D-Market Electronic Services & Trading

D-MARKET Electronic Services & Trading offers an e-commerce platform in Turkey and the surrounding region. The company is comprised of one reportable segment, namely e-commerce operations. The Group derives revenue from the sales of goods, marketplace revenues and other revenues.

Share on Social Networks: